Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYCorbus Pharmaceuticals Completes Enrollment of RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic SclerosisPREV STORYKiniksa Reports First Quarter 2019 Financial Results and Highlights Recent Corporate and Pipeline Activity